{"version":"1.0","type":"link","title":"Imlunestrant with or without abemaciclib in advanced breast cancer: updated efficacy results from the phase III EMBER-3 trial.","author_name":"Jhaveri KL 외","author_url":"https://prs-insight.online/author/Jhaveri%20KL","provider_name":"PRSinsight","provider_url":"https://prs-insight.online","thumbnail_url":"https://prs-insight.online/og/paper/78993","thumbnail_width":1200,"thumbnail_height":630}